share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga ·  Dec 7, 2023 08:07

Gainers

  • Dare Bioscience (NASDAQ:DARE) shares rose 31.1% to $0.46 during Thursday's pre-market session. The company's market cap stands at $44.8 million.
  • Anixa Biosciences (NASDAQ:ANIX) shares moved upwards by 20.35% to $4.73. The market value of their outstanding shares is at $146.9 million.
  • Vanda Pharma (NASDAQ:VNDA) stock rose 20.04% to $4.85. The market value of their outstanding shares is at $279.0 million.
  • Oncternal Therapeutics (NASDAQ:ONCT) shares moved upwards by 15.48% to $0.44. The market value of their outstanding shares is at $25.9 million.
  • Cerevel Therapeutics Hldg (NASDAQ:CERE) shares rose 14.54% to $42.3. The company's market cap stands at $7.6 billion.
  • Atara Biotherapeutics (NASDAQ:ATRA) stock increased by 14.32% to $0.75. The market value of their outstanding shares is at $76.8 million.

Losers

  • Phio Pharma (NASDAQ:PHIO) stock decreased by 34.0% to $1.05 during Thursday's pre-market session. The company's market cap stands at $2.5 million.
  • Modular Medical (NASDAQ:MODD) shares declined by 27.47% to $1.03. The market value of their outstanding shares is at $21.8 million.
  • WAVE Life Sciences (NASDAQ:WVE) shares decreased by 22.57% to $5.32. The market value of their outstanding shares is at $526.9 million.
  • Lucy Scientific Discovery (NASDAQ:LSDI) stock decreased by 13.42% to $0.32. The company's market cap stands at $5.6 million.
  • Geovax Labs (NASDAQ:GOVX) stock decreased by 11.26% to $0.35. The market value of their outstanding shares is at $9.4 million.
  • Eterna Therapeutics (NASDAQ:ERNA) shares fell 9.89% to $1.35. The company's market cap stands at $7.3 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment